Patent Assignment
Reel/Frame 060285/0748
Assignment of Assignor's Interest
Recorded: 2022-06-06
Pages: 33
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Heteroaryl Plasma Kallikrein Inhibitors
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 060111/0256 →
Assignment of Assignor's Interest
Jun 6, 2022
From: PAPAIOANNOU, NIKOLAOS; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0267 →
Assignment of Assignor's Interest
Jun 6, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 060111/0276 →
Assignment of Assignor's Interest
Jun 6, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 060111/0297 →
Assignment of Assignor's Interest
Jun 6, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0310 →
Assignment of Assignor's Interest
Jun 6, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0330 →